Teleflex Incorporated $TFX Shares Sold by Sei Investments Co.

Sei Investments Co. reduced its stake in Teleflex Incorporated (NYSE:TFX) by 38.9% during the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 73,065 shares of the medical technology company’s stock after selling 46,479 shares during the period. Sei Investments Co.’s holdings in Teleflex were worth $8,739,000 at the end of the most recent quarter.

A number of other large investors also recently bought and sold shares of the stock. PNC Financial Services Group Inc. boosted its stake in Teleflex by 11.3% during the first quarter. PNC Financial Services Group Inc. now owns 17,346 shares of the medical technology company’s stock worth $2,075,000 after buying an additional 1,759 shares during the period. Heartland Advisors Inc. raised its stake in shares of Teleflex by 107.8% in the 1st quarter. Heartland Advisors Inc. now owns 215,998 shares of the medical technology company’s stock valued at $25,836,000 after acquiring an additional 112,071 shares during the period. Bessemer Group Inc. raised its stake in shares of Teleflex by 30.5% in the 1st quarter. Bessemer Group Inc. now owns 47,798 shares of the medical technology company’s stock valued at $5,718,000 after acquiring an additional 11,180 shares during the period. Illinois Municipal Retirement Fund lifted its holdings in shares of Teleflex by 17.1% in the 1st quarter. Illinois Municipal Retirement Fund now owns 24,596 shares of the medical technology company’s stock worth $2,942,000 after acquiring an additional 3,591 shares during the last quarter. Finally, Principal Financial Group Inc. lifted its holdings in shares of Teleflex by 2.0% in the 1st quarter. Principal Financial Group Inc. now owns 214,193 shares of the medical technology company’s stock worth $25,620,000 after acquiring an additional 4,214 shares during the last quarter. Institutional investors and hedge funds own 95.62% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of equities analysts recently weighed in on TFX shares. Wells Fargo & Company increased their price objective on shares of Teleflex from $130.00 to $138.00 and gave the stock an “equal weight” rating in a research report on Friday, May 8th. Zacks Research upgraded Teleflex from a “strong sell” rating to a “hold” rating in a research note on Tuesday, April 28th. UBS Group began coverage on Teleflex in a research report on Tuesday. They set a “neutral” rating and a $145.00 price target for the company. Wall Street Zen lowered Teleflex from a “hold” rating to a “sell” rating in a research report on Saturday. Finally, Weiss Ratings reaffirmed a “sell (d)” rating on shares of Teleflex in a research note on Wednesday, June 24th. One research analyst has rated the stock with a Strong Buy rating, four have issued a Buy rating, six have assigned a Hold rating and one has assigned a Sell rating to the company’s stock. Based on data from MarketBeat, the stock has a consensus rating of “Hold” and an average target price of $148.90.

Teleflex Trading Up 3.3%

NYSE TFX opened at $136.72 on Friday. The company has a debt-to-equity ratio of 0.82, a quick ratio of 2.03 and a current ratio of 2.55. The firm has a market cap of $6.05 billion, a price-to-earnings ratio of -6.00, a PEG ratio of 1.02 and a beta of 0.82. The firm has a 50 day simple moving average of $130.96 and a 200-day simple moving average of $121.37. Teleflex Incorporated has a one year low of $100.18 and a one year high of $139.67.

Teleflex (NYSE:TFX) last announced its earnings results on Thursday, May 7th. The medical technology company reported $1.39 earnings per share for the quarter, topping the consensus estimate of $1.21 by $0.18. The firm had revenue of $548.30 million for the quarter, compared to the consensus estimate of $536.91 million. Teleflex had a negative net margin of 35.88% and a positive return on equity of 13.29%. The firm’s revenue for the quarter was up 32.3% on a year-over-year basis. During the same period in the prior year, the firm earned $1.44 EPS. Teleflex has set its FY 2026 guidance at 6.250-6.550 EPS. Equities research analysts anticipate that Teleflex Incorporated will post 6.7 EPS for the current fiscal year.

Teleflex Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Tuesday, June 30th. Stockholders of record on Monday, May 25th were given a dividend of $0.34 per share. The ex-dividend date of this dividend was Friday, May 22nd. This represents a $1.36 dividend on an annualized basis and a dividend yield of 1.0%. Teleflex’s dividend payout ratio is currently -5.96%.

About Teleflex

Teleflex Incorporated is a diversified global provider of medical technologies, specializing in critical care and surgery. Headquartered in Wayne, Pennsylvania, the company designs, manufactures and distributes devices and solutions used by healthcare professionals in hospital, ambulatory and alternate site settings. Teleflex focuses on delivering products that support complex interventional procedures and improve patient outcomes.

The company’s offerings span several key segments, including Interventional Urology, Respiratory & Anesthesia, Surgical, Cardiac Care, Vascular and Original Equipment Manufacturer (OEM) solutions.